Why the study?
Does percutaneous coronary intervention reduce mortality, cardiovascular death, nonfatal myocardial infarction, or revascularization compared to optimal medical therapy in patients with stable coronary artery disease?
Does percutaneous coronary intervention reduce mortality, cardiovascular death, nonfatal myocardial infarction, or revascularization compared to optimal medical therapy in patients with stable coronary artery disease?
In patients with stable coronary artery disease, PCI does not improve hard clinical outcomes compared to optimal medical therapy, though it may offer superior symptom relief.
Answers are grounded in this paper and cite their sources.
Limits PCI to symptom relief in stable CAD; confirms no hard-endpoint benefit versus OMT.
In this most rigorous and comprehensive analysis in patients with stable coronary artery disease, PCI, as compared with OMT, did not reduce the risk of mortality, cardiovascular death, nonfatal myocardial infarction, or revascularization. PCI, however, provided a greater angina relief compared with OMT alone, larger studies with sufficient power are required to prove this conclusively.
No takes yet. Share an insight, caveat, or question.
Pursnani et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: